OKYO Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2022	2021	2020	2019
Market Capitalization	49	47	-	-	-
Enterprise Value	47	45	-3	-7	-0
PE Ratio	-3.55	-3.55	-	-	-
PB Ratio	-22.98	-22.98	-	-	-
P/FCF Ratio	-6.13	-6.13	-	-	-
P/OCF Ratio	-6.13	-6.13	-	-	-
EV/EBITDA Ratio	-3.44	-3.44	0.43	2.02	0.13
EV/EBIT Ratio	-3.44	-3.44	0.43	2.01	0.13
EV/FCF Ratio	-5.89	-5.89	0.49	4.23	0.17
Debt / Equity Ratio	-1.08	-1.08	-	0.02	-0.23
Debt / EBITDA Ratio	-0.17	-0.17	-	-0.03	-0.02
Debt / FCF Ratio	-0.29	-0.29	-	-0.06	-0.03
Quick Ratio	0.64	0.64	2.60	4.08	0.69
Current Ratio	0.72	0.72	3.17	4.09	0.80
Interest Coverage	-136.39	-136.39	-	-3007.46	-1398.26
Return on Equity (ROE)	-2968.50%	-2968.50%	-131.40%	-129.50%	-
Return on Assets (ROA)	-279.30%	-279.30%	-95.30%	-87.20%	-
Return on Capital (ROIC)	-8146.58%	-8146.58%	-210.95%	-62.13%	1415.40%
Earnings Yield	-27.25%	-28.13%	-	-	-
FCF Yield	-15.81%	-16.32%	-	-	-
Buyback Yield / Dilution	-29.71%	-29.71%	-	-	-
Total Shareholder Return	-29.71%	-29.71%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).